N. Orchi

发表

Antiretroviral treatment‐based cost saving interventions may offset expenses for new patients and earlier treatment start

G. Ippolito, A. Mammone, P. Lorenzini, 2014, HIV medicine.

Evaluation in a clinical setting of the performances of a new rapid confirmatory assay for HIV1/2 serodiagnosis.

G. Ippolito, M. Capobianchi, I. Abbate, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Ageing with HIV: newly diagnosed older adults in Italy

G. Ippolito, V. Puro, G. De Carli, 2008, AIDS care.

IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.

C. Gioia, D. Goletti, V. Vanini, 2012, The Journal of infection.

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs

F. Ceccherini‐Silberstein, M. Ciccozzi, C. Perno, 2009, BMC infectious diseases.

Nonnucleoside reverse transcriptase inhibitor-containing regimens are associated with increased satisfaction with sexual life.

A. Wu, B. Longo, R. Murri, 2003, Journal of acquired immune deficiency syndromes.

Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: a multicentre study promoted by the Italian Society of Infectious and Tropical Diseases.

A. Giannetti, A. Antinori, A. Calcagno, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy

F. Ceccherini‐Silberstein, E. Nicastri, A. Antinori, 2015, PloS one.

Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study

C. Agrati, F. Perna, A. Sacchi, 2019, PloS one.

Metabolic and Morphologic Disorders in Patients Treated with Highly Active Antiretroviral Therapy since Primary HIV Infection

G. D'offizi, P. Narciso, V. Tozzi, 2001, Annals of the New York Academy of Sciences.

Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine

C. Agrati, E. Cimini, C. Castilletti, 2022, Scientific Reports.

Molecular Transmission Dynamics of Primary HIV Infections in Lazio Region, Years 2013–2020

M. Capobianchi, A. Antinori, V. Puro, 2021, Viruses.

The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis

G. Ippolito, A. Corpolongo, V. Puro, 2013, BMC Infectious Diseases.

Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection

C. Agrati, M. Capobianchi, A. Antinori, 2022, Pharmaceuticals.

Early ART in primary HIV infection may also preserve lymphopoiesis capability in circulating haematopoietic progenitor cells: a case report.

C. Agrati, E. Cimini, A. Sacchi, 2015, The Journal of antimicrobial chemotherapy.

HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy

G. Ippolito, A. Mammone, P. Pezzotti, 2012, BMC Infectious Diseases.

Effective Highly Active Antiretroviral Therapy in Patients With Primary HIV-1 Infection Prevents the Evolution of the Avidity of HIV-1-Specific Antibodies

G. Ippolito, A. Corpolongo, M. Capobianchi, 2007, Journal of acquired immune deficiency syndromes.

Determinants of health-related quality of life in HIV-infected patients

A. Wu, V. Tozzi, R. Murri, 2003, AIDS care.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy

F. Ceccherini‐Silberstein, O. Turriziani, A. Antinori, 2019, Sexually Transmitted Infections.

Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors.

A. Wu, R. Murri, F. Suter, 1999, Journal of acquired immune deficiency syndromes.

The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro.

F. Ceccherini‐Silberstein, A. Antinori, R. Bellagamba, 2016, Journal of global antimicrobial resistance.

Short-term adverse effects from and discontinuation of antiretroviral post-exposure prophylaxis.

M. Massari, G. Ippolito, V. Puro, 2001, Journal of biological regulators and homeostatic agents.

Consent policies and rates of HIV testing.

G. Ippolito, V. Puro, G. De Carli, 2007, JAMA.

HIV Infection among Low-Risk First Lifetime Testers in Rome, 1990–2000

G. Ippolito, E. Nicastri, D. Serraino, 2005, Infection.

Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000–14

A. Mariano, F. Ceccherini‐Silberstein, V. Vullo, 2017, The Journal of antimicrobial chemotherapy.

Temporal trend and characteristics of recent HIV-1 infections: application of an algorithm for the identification of recently acquired HIV-1 infections among newly diagnosed individuals over a 10-year period.

M. Capobianchi, C. Vlassi, V. Puro, 2013, The new microbiologica.

Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics

F. Martini, A. Antinori, V. Puro, 2014, Journal of the International AIDS Society.

'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing.

F. Ceccherini‐Silberstein, P. Narciso, M. Capobianchi, 2011, The Journal of antimicrobial chemotherapy.

Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, K. Theys, 2013, The Journal of antimicrobial chemotherapy.

Intact provirus and integration sites analysis in acute HIV-1 infection and changes after one year of early antiviral therapy

A. Antinori, V. Puro, E. Girardi, 2022, Journal of virus eradication.

Changing patterns of "hospital-at-home" care use by persons with AIDS in the era of combination antiretroviral therapy.

G. Ippolito, C. Perucci, E. Girardi, 2001, AIDS patient care and STDs.

Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, K. Theys, 2013, The Journal of antimicrobial chemotherapy.

Unawareness of HCV serostatus among persons newly diagnosed with HIV.

C. Agrati, G. Ippolito, A. Antinori, 2019, Journal of infection and public health.

Predisposition of antiretroviral prophylaxis for solid organ transplantation in human immunodeficiency virus‐infected patients

G. Ippolito, V. Puro, N. Orchi, 2005, Transplant infectious disease : an official journal of the Transplantation Society.